Published in Br J Haematol on February 01, 1997
A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa. N Engl J Med (2014) 1.36
Neonatal erythropoiesis and subsequent anemia in HIV-positive and HIV-negative Zimbabwean babies during the first year of life: a longitudinal study. BMC Infect Dis (2006) 1.06
Anaemia in acute HIV-1 subtype C infection. PLoS One (2008) 0.96
Effect on longitudinal growth and anemia of zinc or multiple micronutrients added to vitamin A: a randomized controlled trial in children aged 6-24 months. BMC Public Health (2010) 0.92
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol (2013) 0.88
Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol (2013) 0.88
Association between breast milk erythropoietin and reduced risk of mother-to-child transmission of HIV. J Infect Dis (2010) 0.81
The Kynurenine Pathway of Tryptophan Catabolism and AIDS-Associated Kaposi Sarcoma in Africa. J Acquir Immune Defic Syndr (2015) 0.79
Shock-wave lithotripsy of gallbladder stones. The first 175 patients. N Engl J Med (1988) 5.53
Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet (2005) 3.97
Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. AIDS (1997) 2.82
Fragmentation of gallstones by extracorporeal shock waves. N Engl J Med (1986) 2.76
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial. Scand J Gastroenterol (2002) 2.54
Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood (1999) 2.35
A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut (1997) 2.32
Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Clostridium difficile infection in patients with neutropenia. Clin Infect Dis (2001) 2.00
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut (2005) 1.99
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients. Support Care Cancer (2002) 1.95
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia. Hepatology (1996) 1.88
Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2. Clin Genet (2008) 1.77
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol (1991) 1.76
Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol (1995) 1.71
Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70
Dormia baskets impacted in the bile duct: release by extracorporeal shock-wave lithotripsy. Endoscopy (1995) 1.70
Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection. Eur J Clin Invest (1999) 1.68
Comparison of capsule endoscopy and magnetic resonance imaging for the detection of polyps of the small intestine in patients with familial adenomatous polyposis or with Peutz-Jeghers' syndrome. Endoscopy (2004) 1.64
Gallstones: pathogenesis. Lancet (1991) 1.64
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Gallstone recurrence after shock-wave therapy. Gastroenterology (1994) 1.59
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer (2003) 1.57
Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin. Endoscopy (2002) 1.51
Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem (2001) 1.50
Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology (2000) 1.49
Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology (1991) 1.47
Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol (2001) 1.47
Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. Am J Gastroenterol (2000) 1.46
[Symptoms, tumor stage and primary treatment in patients with colorectal carcinoma]. Dtsch Med Wochenschr (1997) 1.46
[Fatty liver and increased serum lactate in a woman with HIV]. Dtsch Med Wochenschr (2003) 1.44
A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet (2013) 1.43
Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation (1983) 1.42
Surgical intervention following fragmentation of gallstones by extracorporeal shock waves. World J Surg (1989) 1.42
[Fecal incontinence]. Internist (Berl) (2000) 1.42
Haemopoietic, thrombopoietic, and vascular endothelial growth factor in space. Lancet (1999) 1.41
Serum bile acids: physiology and clinical relevance. Eur J Gastroenterol Hepatol (1995) 1.41
Erythropoietin production and pH. Lancet (1992) 1.40
[Therapy-refractory thrombocytopenia in chronic hepatitis C]. Z Gastroenterol (2000) 1.39
[The therapy of the hepatorenal syndrome in liver cirrhosis]. Dtsch Med Wochenschr (1999) 1.39
Detection of four apple viruses by multiplex RT-PCR assays with coamplification of plant mRNA as internal control. J Virol Methods (2002) 1.36
Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem J (1994) 1.36
Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis. Biomed Pharmacother (1999) 1.33
Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of Mycobacterium tuberculosis. Lancet (1995) 1.32
The family Closteroviridae revised. Arch Virol (2002) 1.32
Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol (1998) 1.29
A novel minimal-size vector (MIDGE) improves transgene expression in colon carcinoma cells and avoids transfection of undesired DNA. Mol Ther (2001) 1.28
Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA. HIV Med (2013) 1.28
Mechanism of cytotoxicity induced by chimeric mouse human monoclonal antibody IDEC-C2B8 in CD20-expressing lymphoma cell lines. Cell Immunol (2000) 1.28
Severe cutaneous reactions to self-defense sprays. Arch Dermatol (1993) 1.28
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Pericellular PO2 and O2 consumption in monolayer cell cultures. Respir Physiol (1995) 1.27
Fecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol (1995) 1.27
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology (2001) 1.25
Hydroxylation of hypoxia-inducible transcription factors and chemical compounds targeting the HIF-alpha hydroxylases. Curr Med Chem (2007) 1.24
Mechanisms of extrahepatic vasodilation in portal hypertension. Gut (2008) 1.23
The Munich Gallbladder Lithotripsy Study. Results of the first 5 years with 711 patients. Ann Intern Med (1991) 1.23
Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother (2001) 1.21
S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol (2010) 1.20
Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int (2000) 1.20
Decreased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine secretion in chronic hepatitis C. J Hepatol (1999) 1.20
Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant (2005) 1.20
Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology (1992) 1.19
A retrospective analysis of 3 year's experience of an interdisciplinary approach to gallstone disease including shock-waves. Ann Surg (1988) 1.19
Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood (2001) 1.19
Shock-wave therapy of gastric outlet syndrome caused by a gallstone. Gastroenterology (1989) 1.19
Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta (1996) 1.18
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat (2006) 1.17
Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer. Br J Cancer (2012) 1.17
[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]. Z Gastroenterol (2012) 1.17
Modified rapid urease test for detection of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1996) 1.16
Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy (2009) 1.16
Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids. Gut (1987) 1.14
Complete genome sequences of three Erwinia amylovora phages isolated in north america and a bacteriophage induced from an Erwinia tasmaniensis strain. J Bacteriol (2010) 1.14
Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem (2000) 1.13
Hepatitis after chronic abuse of senna. Lancet (1991) 1.13
Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I. J Clin Invest (1985) 1.12
Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet (1986) 1.11
Littoral cell angioma as a rare cause of splenomegaly. Ann Hematol (2001) 1.11